Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-29 Purchase | 2024-01-31 4:26 pm | Tourmaline Bio Inc. | TRML | MCDADE MARK Director | 100,000 | $32.5 | $3,250,000 | 742,209 (Indirect Direct) | View |
| 2023-11-17 Purchase | 2023-11-20 6:15 pm | Tourmaline Bio Inc. | TRML | Kulkarni Sandeep Chidambar CEO | 4,000 | $16.99 | $67,960 | 729,735 (Direct) | View |
| 2023-11-17 Purchase | 2023-11-20 6:14 pm | Tourmaline Bio Inc. | TRML | Thiara Parvinder Director | 1,000 | $17.31 | $17,310 | 83,782 (Direct) | View |
| 2023-10-25 Purchase | 2023-10-27 5:43 pm | Tourmaline Bio Inc. | TRML | Castelein Caley Director | 20,000 | $14.03 | $280,584 | 974,558 (Indirect Direct) | View |
| 2023-10-24 Purchase | 2023-10-26 5:34 pm | Tourmaline Bio Inc. | TRML | Kulkarni Sandeep Chidambar CEO | 9,650 | $11.49 | $110,912 | 725,735 (Direct) | View |
| 2023-10-24 Purchase | 2023-10-26 5:00 pm | Tourmaline Bio Inc. | TRML | KANTOFF AARON Director | 7,500 | $11.86 | $88,950 | 45,391 (Direct) | View |
| 2023-10-24 Purchase | 2023-10-26 4:46 pm | Tourmaline Bio Inc. | TRML | Thiara Parvinder Director | 7,000 | $11.08 | $77,540 | 82,782 (Direct) | View |
| 2023-06-12 Sale | 2023-06-14 6:58 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 44,020 | $2.5513 | $112,307 | 5,100,302 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-13 Option Award | 2023-12-15 4:23 pm | N/A 2033-12-12 | Tourmaline Bio Inc. | TRML | SIEGALL CLAY B Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-10-23 Option Award | 2023-10-23 8:33 pm | N/A 2033-10-22 | Tourmaline Bio Inc. | TRML | Thiara Parvinder Director | 85,782 | $0 | 85,782 (Direct) | View |
| 2023-10-19 Disposition | 2023-10-23 8:31 pm | N/A 2033-06-13 | Tourmaline Bio Inc. | TRML | Srivastava Sapna Director | 20,500 | $0 | 20,518 (Direct) | View |
| 2023-10-23 Option Award | 2023-10-23 8:31 pm | N/A 2033-10-22 | Tourmaline Bio Inc. | TRML | Srivastava Sapna Director | 20,518 | $0 | 20,518 (Direct) | View |
| 2023-10-19 Option Award | 2023-10-23 8:30 pm | N/A 2033-08-14 | Tourmaline Bio Inc. | TRML | Robinson Ryan F. Interim CFO | 56,211 | $0 | 56,211 (Direct) | View |
| 2023-10-19 Option Award | 2023-10-23 8:29 pm | N/A 2033-06-17 | Tourmaline Bio Inc. | TRML | MIDDLEKAUFF W BRADFORD CBO, GC and Secretary | 240,966 | $0 | 240,966 (Direct) | View |
| 2023-10-19 Disposition | 2023-10-23 8:26 pm | N/A 2033-06-13 | Tourmaline Bio Inc. | TRML | MCDADE MARK Director | 20,500 | $0 | 662,209 (Direct) | View |
| 2023-10-23 Option Award | 2023-10-23 8:26 pm | N/A 2033-10-22 | Tourmaline Bio Inc. | TRML | MCDADE MARK Director | 368,949 | $0 | 662,209 (Direct) | View |
| 2023-10-19 Option Award | 2023-10-23 8:25 pm | N/A 2033-06-17 | Tourmaline Bio Inc. | TRML | Kulkarni Sandeep Chidambar CEO | 1,499,086 | $0 | 1,499,086 (Direct) | View |
| 2023-10-19 Option Award | 2023-10-23 8:24 pm | N/A 2033-02-02 | Tourmaline Bio Inc. | TRML | KANTOFF AARON Director | 85,781 | $0 | 85,781 (Direct) | View |
| 2023-10-19 Option Award | 2023-10-23 8:23 pm | N/A 2033-06-17 | Tourmaline Bio Inc. | TRML | Jones Susan Dana Chief Technology Officer | 145,927 | $0 | 145,927 (Direct) | View |
| 2023-10-19 Option Award | 2023-10-23 8:21 pm | N/A 2033-06-17 | Tourmaline Bio Inc. | TRML | Johnson Kevin Bruce Chief Regulatory Officer | 200,754 | $0 | 200,754 (Direct) | View |
| 2023-10-19 Option Award | 2023-10-23 8:20 pm | N/A 2033-06-17 | Tourmaline Bio Inc. | TRML | CHYUNG YUNG H. Chief Medical Officer | 274,262 | $0 | 274,262 (Direct) | View |
| 2023-10-23 Option Award | 2023-10-23 8:18 pm | N/A 2033-10-22 | Tourmaline Bio Inc. | TRML | Castelein Caley Director | 964,558 | $0 | 964,558 (Direct) | View |
| 2023-07-03 Tax Withholding | 2023-07-06 5:20 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Fenton Mary Kay Chief Financial Officer | 12,946 | $3.08 | 68,054 (Direct) | View |
| 2023-07-03 Tax Withholding | 2023-07-06 5:19 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Requadt Scott Former Chief Executive Officer | 11,786 | $3.08 | 1,028,169 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-14 7:03 pm | N/A 2033-06-13 | Talaris Therapeutics Inc. | TALS | Srivastava Sapna Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-14 7:02 pm | N/A 2033-06-13 | Talaris Therapeutics Inc. | TALS | Smith Karen L. Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-14 7:01 pm | N/A 2033-06-13 | Talaris Therapeutics Inc. | TALS | Shah Gaurav Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-14 7:00 pm | N/A 2033-06-13 | Talaris Therapeutics Inc. | TALS | Nader Francois Director | 41,000 | $0 | 41,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-14 6:59 pm | N/A 2033-06-13 | Talaris Therapeutics Inc. | TALS | MCDADE MARK Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-14 6:59 pm | N/A 2033-06-13 | Talaris Therapeutics Inc. | TALS | MACKAY GEOFFREY Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-14 6:58 pm | N/A 2033-06-13 | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 20,500 | $0 | 5,100,302 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-14 6:56 pm | N/A 2033-06-13 | Talaris Therapeutics Inc. | TALS | Agarwala Sandip Director | 20,500 | $0 | 20,500 (Direct) | View |